{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "regularMarketChangePercent": -1.3565832, "regularMarketPrice": 2.545, "exchange": "FRA", "shortName": "NFL BIOSCIENCES  EO -,03", "longName": "NFL Biosciences SA", "messageBoardId": "finmb_677036256", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketTime": 1683871387, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.19, "sharesOutstanding": 5234610, "fiftyDayAverage": 2.7045, "fiftyDayAverageChange": -0.15949988, "fiftyDayAverageChangePercent": -0.058975738, "twoHundredDayAverage": 2.17465, "twoHundredDayAverageChange": 0.37035012, "twoHundredDayAverageChangePercent": 0.17030333, "marketCap": 13798812, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "prevName": "Nfl Biosciences", "nameChangeDate": "2023-05-11", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1626415200000, "priceHint": 4, "regularMarketChange": -0.034999847, "regularMarketDayHigh": 2.545, "regularMarketDayRange": "2.545 - 2.545", "regularMarketDayLow": 2.545, "regularMarketVolume": 150, "regularMarketPreviousClose": 2.58, "bid": 2.58, "ask": 2.71, "fullExchangeName": "Frankfurt", "regularMarketOpen": 2.545, "averageDailyVolume3Month": 282, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 1.9070001, "fiftyTwoWeekLowChangePercent": 2.9890282, "fiftyTwoWeekRange": "0.638 - 3.35", "fiftyTwoWeekHighChange": -0.8049998, "fiftyTwoWeekHighChangePercent": -0.24029846, "fiftyTwoWeekLow": 0.638, "fiftyTwoWeekHigh": 3.35, "symbol": "82F.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "199 Rue H\u00e9l\u00e8ne Boucher", "city": "Castelnau-le-Lez", "zip": "34170", "country": "France", "phone": "33 4 11 93 76 67", "website": "https://www.nflbiosciences.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "NFL Biosciences SA, a biotechnology company, develops natural addiction withdrawal solutions for smokers. The company's natural drug candidate in pipeline to cure tobacco addiction include NFL-101, a tobacco extract that is in Phase III clinical trial targeting smoking addiction; NFL-201, a cannabis and tobacco extract, which is in preclinical stage; and NFL-301, a botanical extract (traditional Chinese medicine) that is in preclinical stage. NFL Biosciences SA was incorporated in 2006 and is based in Castelnau-le-Lez, France.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Ignacio  Faus M.B.A., Ph.D.", "title": "CEO & Chairman", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Bruno  Lafont M.B.A., M.Sc.", "title": "Co-Founder, COO & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Guillaume  Audema", "title": "Chief Financial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}